Latest / The Bell2Bell (B2B) Podcast

Bell2Bell Podcast featuring CEO Rodney Varner & CFO Ryan Confer of Genprex, Inc. (NASDAQ: GNPX)
Bell2Bell’s latest podcast features Chairman, President and CEO Rodney Varner and CFO Ryan Confer of Genprex, Inc. (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients living with cancer and diabetes.
In this interview, Varner and Confer discuss the journeys that led them to Genprex and the incredible promise of the company’s clinical drug development pipeline.
“This work has become a real passion for me. We have the opportunity to do real good here at Genprex on a major scale – helping millions of people around the world with…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.